Study of Prophylactic Vs Preemptive Valganciclovir

Completed · Not applicable

Conditions studied: Cytomegalovirus Infection

In brief

This is a study of prophylactic Vs preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients looking at clinical and pharmacoeconomic outcomes

Key facts

Study ID

NCT00374686

Run by

Washington University School of Medicine

People needed

120

Starts

2003-03-01

Expected to finish

2005-09-01

Last updated by the study team

2006-09-11

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients who received a kidney transplant at Washington University Medical Center between March 2003 and June 2004.

You may not qualify if…

• Age younger than 18
• Refusal to consent for the study
• Allergy to ganciclovir and severe illness too serious to justify randomization

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.